Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-0.41 Cr₹1.55 Cr₹0.70 Cr₹0.60 Cr₹2.63 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA is ₹-0.41 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-0.41 Cr
Mar2024₹1.55 Cr
Mar2023₹0.70 Cr
Mar2022₹0.60 Cr
Mar2021₹2.63 Cr

How is Deferred Tax Assets / Liabilities of BAL PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-0.41 Cr
Negative
Mar2024 ₹1.55 Cr
120.34
Mar2023 ₹0.70 Cr
16.39
Mar2022 ₹0.60 Cr
-77.05
Mar2021 ₹2.63 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹137.4 Cr 1.5% -3.2% -3.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,952.0 Cr 1% -2.9% 17.4% Stock Analytics
DIVIS LABORATORIES ₹230,427.0 Cr 1.8% 17% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,141.0 Cr -1.9% -1.9% 33.2% Stock Analytics
CIPLA ₹114,715.0 Cr 0.3% 0.7% -7.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,409.9 Cr 1.7% 3.5% -4.1% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

1.5%

-3.2%

-3.6%

SENSEX

0.5%

2.1%

-4.5%


You may also like the below Video Courses